ArticleSTUDY OF THE RELATION BETWEEN RECEIVING ANTI-THYMOCYTE GLOBULIN AND MORBIDITY & MORTALITY IN HAEMATOPOIETIC TRANSPLANTED PATIENTS
ArticleSTUDY OF THE RELATION BETWEEN RECEIVING ANTI-THYMOCYTE GLOBULIN AND MORBIDITY & MORTALITY IN HAEMATOPOIETIC TRANSPLANTED PATIENTS
ArticleRisk Prediction Genetic Study of Non-HLA Gene NOD2 Three Polymorphisms in Acute Graft versus Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
ArticleRisk Prediction Genetic Study of Non-HLA Gene NOD2 Three Polymorphisms in Acute Graft versus Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
ArticleA study on some factors affecting CMV reactivation in allogeneic hematopoietic stem cells transplantation
ArticleA study on some factors affecting CMV reactivation in allogeneic hematopoietic stem cells transplantation
ArticleSTUDY OF THE ASSOCIATION BETWEEN SOME TOLL-LIKE RECEPTORS GENE POLYMORPHISMS AND OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
ArticleSTUDY OF THE ASSOCIATION BETWEEN SOME TOLL-LIKE RECEPTORS GENE POLYMORPHISMS AND OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
ArticleHuman Leucocyte Antigen A Alleles in The Prediction of Post-Kidney Transplant Lymphoproliferative Disorders, A Single-Center Study
ArticleHuman Leucocyte Antigen A Alleles in The Prediction of Post-Kidney Transplant Lymphoproliferative Disorders, A Single-Center Study
ThesisAllogeneic peripheral blood stem cell transplantation in patients with severe aplastic anemia, comparing fludarabine based versus anti-thymocyte globuline based conditioning regimens : A retrospective study
ThesisAllogeneic peripheral blood stem cell transplantation in patients with severe aplastic anemia, comparing fludarabine based versus anti-thymocyte globuline based conditioning regimens : A retrospective study
ArticleHLA DRB1 alleles in association with acute and chronic myeloid leukemia and evaluation of their role as markers for selection of the line of treatment
ArticleHLA DRB1 alleles in association with acute and chronic myeloid leukemia and evaluation of their role as markers for selection of the line of treatment